The purpose of this study is to evaluate the efficacy and safety of treatment with SYR-472 in diabetic patients.
Study Type
INTERVENTIONAL
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
245
Unnamed facility
Akita, Akita, Japan
Unnamed facility
Matsudo-shi, Chiba, Japan
Unnamed facility
Fukuoka, Fukuoka, Japan
Glycosylated hemoglobin (HbA1c)
Measurement of change in HbA1c (ratio of hemoglobin bound to glucose).
Time frame: 24 weeks.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Fukuyama-shi, Hiroshima, Japan
Unnamed facility
Ishikari-shi, Hokkaido, Japan
Unnamed facility
Nakagawa-gun, Hokkaido, Japan
Unnamed facility
Sapporo, Hokkaido, Japan
Unnamed facility
Naka, Ibaragi, Japan
Unnamed facility
Sagamihara-shi, Kanagawa, Japan
Unnamed facility
Kumamoto, Kumamoto, Japan
...and 12 more locations